🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.195
-0.205 (-14.64%)
Nov 20, 2026, 12:30 PM EST - Market open

Acrivon Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5176187109241-
Market Cap Growth
-33.22%-59.43%71.66%-54.61%--
Enterprise Value
-25-504-28291-
Last Close Price
1.402.416.024.9211.52-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
0.850.681.060.901.41-
P/TBV Ratio
0.870.681.060.901.41-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.020.020.040.030.06
Net Debt / Equity Ratio
-1.07-1.03-0.99-1.01-0.72-0.95
Net Debt / EBITDA Ratio
1.001.401.991.853.805.82
Net Debt / FCF Ratio
1.201.772.572.803.806.61
Quick Ratio
5.447.5710.439.5819.6134.18
Current Ratio
5.547.6910.559.7520.2734.46
Return on Equity (ROE)
-74.12%-53.86%-54.07%-41.41%-23.16%-32.40%
Return on Assets (ROA)
-63.96%-47.75%-48.11%-37.80%-21.66%-29.87%
Return on Capital Employed (ROCE)
-108.00%-73.70%-49.70%-53.70%-18.70%-15.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-152.53%-102.44%-42.98%-55.30%-12.95%-
FCF Yield
-103.36%-85.91%-36.51%-40.23%-13.42%-
Buyback Yield / Dilution
-5.53%-13.96%-53.05%-435.63%-136.43%-21.70%
SEC Filings: 10-K · 10-Q